%0 Journal Article
%T Safety of an Abbreviated Transition Period When Switching From Intravenous Immunoglobulin to Eculizumab in Patients with Treatment-Refractory Myasthenia Gravis: A Case Series
%A Todd D. Levine
%J Archive of "The American Journal of Case Reports".
%D 2019
%R 10.12659/AJCR.916424
%K Complement Inactivating Agents
%K Immunoglobulins
%K Intravenous
%K Myasthenia Gravis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628751/